Angiotensin II-Receptor Antagonist Losartan Does not Prevent Nitroglycerin Tolerance in Patients with Coronary Artery Disease

By Longobardi Giancarlo   Ferrara Nicola   Leosco Dario   Abete Pasquale   Furgi Giuseppe   Cacciatore Francesco   Corbi Graziamaria   Pescatore Raffaella   Rengo Franco  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 363-370

Springer Publishing Company

Access to resources Recommend Favorite

The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease

By Brugts J.   Maat M.   Boersma E.   Witteman J.   Duijn C.   Uitterlinden A.   Bertrand M.   Remme W.   Fox K.   Ferrari R.   Danser A.   Simoons M.  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 171-181

Springer Publishing Company

Access to resources Recommend Favorite

Perindopril: A Review of its Use in Patients With or at Risk of Developing Coronary Artery Disease

By Curran Monique P.   McCormack Paul L.   Simpson Dene  

Drugs, Vol. 66, Iss. 2, 2006-01 ,pp. : 235-255

Adis International

Access to resources Recommend Favorite

Matrix Metalloproteinases in Coronary Artery Disease:Clinical and Therapeutic Implications and Pathological Significance

By  

Current Medicinal Chemistry, Vol. 12, Iss. 8, 2005-04 ,pp. : 917-925

Bentham Science Publishers

Access to resources Recommend Favorite

Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease

By Böhm Felix   Jensen Jens   Svane Bertil   Settergren Magnus   Pernow John  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 11, 2008-11 ,pp. : 745-751

NRC Research Press

Access to resources Recommend Favorite